US Physical Therapy Inc has a consensus price target of $102.4, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from JP Morgan, Barrington Research, and Barrington Research on March 13, 2024, March 1, 2024, and January 3, 2024. With an average price target of $119.67 between JP Morgan, Barrington Research, and Barrington Research, there's an implied 15.74% upside for US Physical Therapy Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/13/2024 | USPH | Buy Now | US Physical Therapy | $103.39 | 13.16% | JP Morgan | Calvin Sternick | $99 → $117 | Maintains | Overweight | Get Alert |
03/01/2024 | USPH | Buy Now | US Physical Therapy | $103.39 | 18% | Barrington Research | Michael Petusky | $120 → $122 | Maintains | Outperform | Get Alert |
01/03/2024 | USPH | Buy Now | US Physical Therapy | $103.39 | 16.07% | Barrington Research | Michael Petusky | $111 → $120 | Maintains | Outperform | Get Alert |
11/17/2023 | USPH | Buy Now | US Physical Therapy | $103.39 | -4.25% | JP Morgan | Calvin Sternick | $108 → $99 | Maintains | Overweight | Get Alert |
11/09/2023 | USPH | Buy Now | US Physical Therapy | $103.39 | 7.36% | Barrington Research | Michael Petusky | $124 → $111 | Maintains | Outperform | Get Alert |
09/22/2023 | USPH | Buy Now | US Physical Therapy | $103.39 | 4.46% | JP Morgan | Calvin Sternick | → $108 | Initiates | → Overweight | Get Alert |
09/19/2023 | USPH | Buy Now | US Physical Therapy | $103.39 | — | CJS Securities | Larry Solow | — | Upgrade | Market Perform → Market Outperform | Get Alert |
08/14/2023 | USPH | Buy Now | US Physical Therapy | $103.39 | 19.93% | Barrington Research | Michael Petusky | $116 → $124 | Maintains | Outperform | Get Alert |
06/30/2023 | USPH | Buy Now | US Physical Therapy | $103.39 | 33.48% | B of A Securities | Joanna Gajuk | → $138 | Initiates | → Buy | Get Alert |
05/05/2023 | USPH | Buy Now | US Physical Therapy | $103.39 | 12.2% | Barrington Research | Michael Petusky | $110 → $116 | Maintains | Outperform | Get Alert |
02/24/2023 | USPH | Buy Now | US Physical Therapy | $103.39 | 6.39% | Barrington Research | Michael Petusky | $107 → $110 | Maintains | Outperform | Get Alert |
12/14/2021 | USPH | Buy Now | US Physical Therapy | $103.39 | 16.07% | CJS Securities | Larry Solow | — | Upgrade | Market Perform → Market Outperform | Get Alert |
05/07/2021 | USPH | Buy Now | US Physical Therapy | $103.39 | 25.74% | Barrington Research | Michael Petusky | — | Upgrade | Market Perform → Outperform | Get Alert |
05/03/2021 | USPH | Buy Now | US Physical Therapy | $103.39 | 30.57% | Jefferies | Stephanie Wissink | — | Upgrade | Hold → Buy | Get Alert |
The latest price target for US Physical Therapy (NYSE: USPH) was reported by JP Morgan on March 13, 2024. The analyst firm set a price target for $117.00 expecting USPH to rise to within 12 months (a possible 13.01% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for US Physical Therapy (NYSE: USPH) was provided by JP Morgan, and US Physical Therapy maintained their overweight rating.
The last upgrade for US Physical Therapy Inc happened on September 19, 2023 when CJS Securities raised their price target to N/A. CJS Securities previously had a market perform for US Physical Therapy Inc.
There is no last downgrade for US Physical Therapy.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of US Physical Therapy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for US Physical Therapy was filed on March 13, 2024 so you should expect the next rating to be made available sometime around March 13, 2025.
While ratings are subjective and will change, the latest US Physical Therapy (USPH) rating was a maintained with a price target of $99.00 to $117.00. The current price US Physical Therapy (USPH) is trading at is $103.53, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.